Literature DB >> 30791829

Intraarterial Thrombolysis as Rescue Therapy for Large Vessel Occlusions.

Syed F Zaidi1, Alicia C Castonguay1, Mouhammad A Jumaa1, Tim W Malisch2, Italo Linfante3, Franklin A Marden2, Michael G Abraham4, Alex Bou Chebl5, Roberta Novakovic6, M Asif Taqi7, Raul G Nogueira8, Coleman O Martin9, William E Holloway9, Nils Mueller-Kronast10, Joey D English11, Guilherme Dabus3, Hormozd Bozorgchami12, Andrew Xavier13, Ansaar T Rai14, Michael T Froehler15, Aamir Badruddin16, Thanh N Nguyen17, Albert J Yoo18, Hashem Shaltoni19, Vallabh Janardhan18, Peng R Chen20, Gavin W Britz21, Ritesh Kaushal22, Ashish Nanda23, Rishi Gupta24, Osama O Zaidat25.   

Abstract

Background and Purpose- Mechanical thrombectomy (MT) devices have led to improved reperfusion and clinical outcomes in acute ischemic stroke patients with emergent large vessel occlusions; however, less than one-third of patients achieve complete reperfusion. Use of intraarterial thrombolysis in the context of MT may provide an opportunity to enhance these results. Here, we evaluate the use of intraarterial rtPA (recombinant tissue-type plasminogen activator) as rescue therapy (RT) after failed MT in the North American Solitaire Stent-Retriever Acute Stroke registry. Methods- The North American Solitaire Stent-Retriever Acute Stroke registry recruited sites within North America to submit data on acute ischemic stroke patients treated with the Solitaire device. After restricting the population of 354 patients to use of RT and anterior emergent large vessel occlusions, we compared patients who were treated with and without intraarterial rtPA after failed MT. Results- A total of 37 and 44 patients was in the intraarterial rtPA RT and the no intraarterial rtPA RT groups, respectively. Revascularization success (modified Thrombolysis in Cerebral Infarction ≥2b) was achieved in more intraarterial rtPA RT patients (61.2% versus 46.6%; P=0.13) with faster times to recanalization (100±85 versus 164±235 minutes; P=0.36) but was not statistically significant. The rate of symptomatic intracranial hemorrhage (13.9% versus 6.8%; P=0.29) and mortality (42.9% versus 44.7%; P=0.87) were similar between the groups. Good functional outcome (modified Rankin Scale score of ≤2) was numerically higher in intraarterial rtPA patients (22.9% versus 18.4%; P=0.64). Further restriction of the RT population to M1 occlusions only and time of onset to groin puncture ≤8 hours, resulted in significantly higher successful revascularization rates in the intraarterial rtPA RT cohort (77.8% versus 38.9%; P=0.02). Conclusions- Intraarterial rtPA as RT demonstrated a similar safety and clinical outcome profile, with higher reperfusion rates achieved in patients with M1 occlusions. Prospective studies are needed to delineate the role of intraarterial thrombolysis in MT.

Entities:  

Keywords:  occlusion; reperfusion; standard of care; stroke; thrombectomy

Mesh:

Substances:

Year:  2019        PMID: 30791829     DOI: 10.1161/STROKEAHA.118.024442

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  6 in total

1.  Safety and Efficacy of Intra-arterial Urokinase After Failed, Unsuccessful, or Incomplete Mechanical Thrombectomy in Anterior Circulation Large-Vessel Occlusion Stroke.

Authors:  Johannes Kaesmacher; Sebastian Bellwald; Tomas Dobrocky; Thomas R Meinel; Eike I Piechowiak; Martina Goeldlin; Christoph C Kurmann; Mirjam R Heldner; Simon Jung; Pasquale Mordasini; Marcel Arnold; Pascal J Mosimann; Gerhard Schroth; Heinrich P Mattle; Jan Gralla; Urs Fischer
Journal:  JAMA Neurol       Date:  2020-03-01       Impact factor: 18.302

2.  Accelerated sonothrombolysis with Definity in a xenographic porcine cerebral thromboembolism model.

Authors:  Robert T Kleven; Kunal B Karani; Nicole Hilvert; Samantha M Ford; Karla P Mercado-Shekhar; John M Racadio; Marepalli B Rao; Todd A Abruzzo; Christy K Holland
Journal:  Sci Rep       Date:  2021-02-17       Impact factor: 4.379

3.  Safety and Angiographic Efficacy of Intra-Arterial Fibrinolytics as Adjunct to Mechanical Thrombectomy: Results from the INFINITY Registry.

Authors:  Johannes Kaesmacher; Nuran Abdullayev; Basel Maamari; Tomas Dobrocky; Jan Vynckier; Eike I Piechowiak; Raoul Pop; Daniel Behme; Peter B Sporns; Hanna Styczen; Pekka Virtanen; Lukas Meyer; Thomas R Meinel; Daniel Cantré; Christoph Kabbasch; Volker Maus; Johanna Pekkola; Sebastian Fischer; Anca Hasiu; Alexander Schwarz; Moritz Wildgruber; David J Seiffge; Sönke Langner; Nicolas Martinez-Majander; Alexander Radbruch; Marc Schlamann; Dan Mihoc; Rémy Beaujeux; Daniel Strbian; Jens Fiehler; Pasquale Mordasini; Jan Gralla; Urs Fischer
Journal:  J Stroke       Date:  2021-01-31       Impact factor: 6.967

Review 4.  Recanalization Therapy for Acute Ischemic Stroke with Large Vessel Occlusion: Where We Are and What Comes Next?

Authors:  Mohammad Shafie; Wengui Yu
Journal:  Transl Stroke Res       Date:  2021-01-06       Impact factor: 6.829

5.  Insights Into Intra-arterial Thrombolysis in the Modern Era of Mechanical Thrombectomy.

Authors:  Alicia C Castonguay; Mouhammad A Jumaa; Osama O Zaidat; Diogo C Haussen; Ashutosh Jadhav; Hisham Salahuddin; Syed F Zaidi
Journal:  Front Neurol       Date:  2019-11-13       Impact factor: 4.003

6.  Multiphysics Modelling and Simulation of Thrombolysis via Activated Platelet-Targeted Nanomedicine.

Authors:  Boram Gu; Yu Huang; Emily Louise Manchester; Alun D Hughes; Simon A McG Thom; Rongjun Chen; Xiao Yun Xu
Journal:  Pharm Res       Date:  2022-01-19       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.